NCT00875316View on ClinicalTrials.gov

Safety and Tolerability Study of Cogane™ in Healthy Volunteers and Parkinson's Disease Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Parkinson's Disease

Interventions

DRUG

Cogane™ (PYM50028)

Orally active neurotrophic factor inducer

Trial Locations (1)

CB23 2TN

LCG Bioscience, Bourn

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Phytopharm

INDUSTRY

NCT00875316 - Safety and Tolerability Study of Cogane™ in Healthy Volunteers and Parkinson's Disease Patients | Biotech Hunter | Biotech Hunter